Compare Pfizer Inc (PFE) vs XP Inc. Class A Common Stock (XP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs XP Inc. Class A Common Stock — how do they compare? Pfizer Inc trades at $28.21 (market cap $158.56B), while XP Inc. Class A Common Stock trades at $31.99 (market cap $15.33B). The key difference: Pfizer Inc is far larger — about 10.3× XP Inc. Class A Common Stock's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and XP Inc. Class A Common Stock for 0 Days on average.
| PFE | XP | |
|---|---|---|
Market Cap | $158.56B | $15.33B |
Volume | 44,138,282 | 14,214,379 |
Sector | Health | Financials |
52-Week High | $29.02 | $30.21 |
52-Week Low | $23.67 | $14.94 |
Typical Hold Time | 158 Days | 0 Days |
Enterprise Value | $210.06B | $24.96B |
Dividend Yield | 6.18% | 0.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About XP Inc. Class A Common Stock
XP Inc. provides investment products and financial services in Brazil. Its platform includes brokerage, investment funds, fixed-income products, banking, insurance, and retirement solutions.
Read more on XP →
